Aguilar, Violeta T.
HRN: 29-07-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
CEFUROXIME 500MG (TAB)
06/23/2026
06/29/2026
PO
500mg
BID
SP D&C, Polypectomy
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines